Structures by: Hökelek T.
Total: 381
6-Bromo-2-(4-chlorophenyl)-3-[(1-octyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C23H26BrClN6
IUCrData (2019) 4, 1 x190053
a=16.252(3)Å b=5.3787(9)Å c=27.109(4)Å
α=90° β=90.551(12)° γ=90°
C24H28O8
C24H28O8
New Journal of Chemistry (2020) 44, 36 15515-15525
a=14.2917(15)Å b=5.5579(6)Å c=14.5639(14)Å
α=90° β=111.471(7)° γ=90°
C30H40Cl2Fe2N7P3
C30H40Cl2Fe2N7P3
New Journal of Chemistry (2018) 42, 3 1740
a=9.2205(3)Å b=18.7632(5)Å c=19.8553(5)Å
α=90.00° β=97.007(3)° γ=90.00°
C30H40Cl2Fe2N7P3
C30H40Cl2Fe2N7P3
New Journal of Chemistry (2018) 42, 3 1740
a=12.0597(3)Å b=12.0704(3)Å c=13.6777(4)Å
α=94.870(3)° β=94.937(3)° γ=118.558(4)°
C30H40Cl2Fe2N7P3
C30H40Cl2Fe2N7P3
New Journal of Chemistry (2018) 42, 3 1740
a=14.6671(3)Å b=16.1963(4)Å c=17.2882(4)Å
α=85.935(4)° β=69.201(3)° γ=64.861(3)°
C22H16O3S
C22H16O3S
New Journal of Chemistry (2019) 43, 15 5737
a=9.9226(2)Å b=15.7155(3)Å c=11.5782(2)Å
α=90.00° β=108.572(3)° γ=90.00°
C14H17Cl6FeN5OP4
C14H17Cl6FeN5OP4
New Journal of Chemistry (2019) 43, 18 6856
a=13.9606(4)Å b=11.0102(3)Å c=16.3482(5)Å
α=90.00° β=98.192(3)° γ=90.00°
C14H22Cl8N10P6
C14H22Cl8N10P6
New J. Chem. (2016) 40, 11 9609
a=9.4119(4)Å b=33.4898(13)Å c=10.4590(4)Å
α=90° β=97.3160(10)° γ=90°
C23H42N8OP3
C23H42N8OP3
New J. Chem. (2016) 40, 11 9609
a=38.868(2)Å b=9.1882(6)Å c=16.6047(10)Å
α=90° β=104.465(3)° γ=90°
C16H26Cl8N10P6
C16H26Cl8N10P6
New J. Chem. (2016) 40, 11 9609
a=12.5574(6)Å b=17.0478(8)Å c=16.6323(8)Å
α=90° β=108.227(2)° γ=90°
C20H26Cl4F2N8P4
C20H26Cl4F2N8P4
New J. Chem. (2017)
a=8.5886(2)Å b=9.2505(3)Å c=9.5924(3)Å
α=75.382(3)° β=71.148(3)° γ=87.868(3)°
C22H30Cl4F2N8P4
C22H30Cl4F2N8P4
New J. Chem. (2017)
a=37.3694(12)Å b=10.3766(3)Å c=15.8615(5)Å
α=90.00° β=90.00° γ=90.00°
C22H30Cl4F2N8P4
C22H30Cl4F2N8P4
New J. Chem. (2017)
a=8.8404(3)Å b=19.0391(5)Å c=9.1699(3)Å
α=90.00° β=101.828(2)° γ=90.00°
C18H20Cl2N5O2P3,C6H6
C18H20Cl2N5O2P3,C6H6
New J. Chem. (2015) 39, 11 8825
a=9.6261(3)Å b=10.9469(3)Å c=14.6288(4)Å
α=72.336(3)° β=89.163(3)° γ=65.679(2)°
5a
C39H68FeN12P4
New J. Chem. (2016) 40, 6 5588
a=32.5727(6)Å b=11.6539(3)Å c=22.8510(5)Å
α=90.00° β=92.546(2)° γ=90.00°
4a
C38H66FeN12P4
New J. Chem. (2016) 40, 6 5588
a=33.4714(6)Å b=11.0459(3)Å c=23.2196(4)Å
α=90.00° β=94.801(2)° γ=90.00°
C28H36Cl2Fe2N7P3
C28H36Cl2Fe2N7P3
New Journal of Chemistry (2018) 42, 3 1740
a=33.5336(6)Å b=13.8058(3)Å c=15.6001(4)Å
α=90.00° β=111.439(2)° γ=90.00°
C20H44N2O9I2Na2
C20H44N2O9I2Na2
Journal of the Chemical Society, Dalton Transactions (1998) 21 3635
a=15.798(1)Å b=11.148(1)Å c=17.643(1)Å
α=90° β=100.79(1)° γ=90°
C20H44N2O9I2K2
C20H44N2O9I2K2
Journal of the Chemical Society, Dalton Transactions (1998) 21 3635
a=9.678(2)Å b=9.680(1)Å c=17.648(2)Å
α=81.22(2)° β=81.20(2)° γ=70.46(2)°
NA8
C15H14N2O2
Acta Crystallographica Section E Crystallographic Communications (2020) 76, 4 467
a=8.4959(2)Å b=9.6479(2)Å c=8.7619(2)Å
α=90° β=116.9210(10)° γ=90°
6,6,12,12-Tetrachlorotricyclo[8.2.0.0^4,7^]dodecane-5,11-dione
C12H12Cl4O2
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 9 1000
a=10.9786(3)Å b=10.9374(3)Å c=23.5429(5)Å
α=90.00° β=97.554(2)° γ=90.00°
6-Bromo-3-(5-bromohexyl)-2-[4-(dimethylamino)phenyl]-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C20H24Br2N4
Acta Crystallographica Section E (2020) 76, 8 1234-1238
a=8.1488(11)Å b=11.2243(15)Å c=12.6378(17)Å
α=64.049(2)° β=74.184(2)° γ=86.067(2)°
4-[(4-Allyl-2-methoxyphenoxy)methyl]-1-(4-methoxyphenyl)-1<i>H</i>-1,2,3-triazole
C20H21N3O3
Acta Crystallographica Section E (2020) 76, 6 962-966
a=16.212(3)Å b=5.9584(12)Å c=19.450(4)Å
α=90° β=110.537(3)° γ=90°
(<i>Z</i>)-4-Hexyl-2-(4-methylbenzylidene)-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C22H25NOS
Acta Crystallographica Section E (2020) 76, 6 889-895
a=8.8581(19)Å b=9.183(2)Å c=13.021(3)Å
α=106.474(3)° β=109.398(3)° γ=93.383(3)°
2-(2,3-Dihydro-1<i>H</i>-perimidin-2-yl)phenol
C17H14N2O
Acta Crystallographica Section E (2020) 76, 6 798-802
a=9.0710(4)Å b=12.0526(7)Å c=24.6120(11)Å
α=90° β=95.999(4)° γ=90°
6-Bromo-3-(12-bromododecyl)-2-(4-nitrophenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C24H30Br2N4O2
Acta Crystallographica Section E (2020) 76, 5 677-682
a=6.3291(11)Å b=9.8911(17)Å c=21.133(4)Å
α=76.480(2)° β=84.965(3)° γ=73.891(2)°
Ethyl 2-[(2<i>Z</i>)-2-(2-chlorobenzylidene)-3-oxo-3,4-dihydro-2<i>H</i>-\ 1,4-benzothiazin-4-yl]acetate
C19H16ClNO3S
Acta Crystallographica Section E (2020) 76, 5 629-636
a=11.6882(2)Å b=9.0903(2)Å c=16.9533(3)Å
α=90° β=105.1050(10)° γ=90°
2-(2,3-Dihydro-1<i>H</i>-perimidin-2-yl)-6-methoxyphenol
C18H16N2O2
Acta Crystallographica Section E (2020) 76, 5 605-610
a=12.7245(7)Å b=9.5887(6)Å c=23.7276(14)Å
α=90° β=90° γ=90°
1,3-Bis[2-methoxy-4-(prop-2-en-1-yl)phenoxy]propane
C23H28O4
Acta Crystallographica Section E (2020) 76, 3 344-348
a=15.4741(5)Å b=5.0224(2)Å c=25.5180(9)Å
α=90° β=99.858(2)° γ=90°
1-(1,3-Benzothiazol-2-yl)-3-(2-hydroxyethyl)imidazolidin-2-one
C12H13N3O2S
Acta Crystallographica Section E (2020) 76, 3 370-376
a=7.2863(2)Å b=13.9178(5)Å c=11.6156(4)Å
α=90° β=98.8660(10)° γ=90°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-nonyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C24H27Cl2NOS
Acta Crystallographica Section E (2020) 76, 2 281-287
a=8.9961(3)Å b=10.3755(3)Å c=13.2565(4)Å
α=73.8570(10)° β=88.1190(10)° γ=74.1820(10)°
1-Benzyl-3-[(1-benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one monohydrate
C24H21N5O,H2O
Acta Crystallographica Section E (2020) 76, 1 95-101
a=9.0872(2)Å b=21.1012(4)Å c=11.7134(2)Å
α=90° β=112.6540(10)° γ=90°
1-Methyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C11H10N2O
Acta Crystallographica Section E (2019) 75, 12 1940-1946
a=7.1507(3)Å b=8.8177(4)Å c=15.4602(7)Å
α=90° β=97.914(2)° γ=90°
Ethyl 2-{4-[(2-ethoxy-2-oxoethyl)(phenyl)carbamoyl]-2-oxo-1,2-\ dihydroquinolin-1-yl}acetate
C24H24N2O6
Acta Crystallographica Section E (2019) 75, 11 1753-1758
a=16.9368(5)Å b=15.4130(4)Å c=18.4562(6)Å
α=90° β=109.254(4)° γ=90°
Methyl 4-[3,6-bis(pyridin-2-yl)pyridazin-4-yl]benzoate
C22H16N4O2
Acta Crystallographica Section E (2019) 75, 11 1672-1678
a=6.04640(10)Å b=11.7175(3)Å c=13.2931(3)Å
α=95.7350(10)° β=95.8130(10)° γ=101.7800(10)°
(2<i>Z</i>)-4-Benzyl-2-(2,4-dichlorobenzylidene)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C22H15Cl2NOS
Acta Crystallographica Section E (2019) 75, 11 1650-1656
a=9.0373(7)Å b=16.6798(13)Å c=12.5110(10)Å
α=90° β=95.982(2)° γ=90°
3,4-Dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine
C20H17N3O3
Acta Crystallographica Section E (2019) 75, 1 94-98
a=10.509(9)Å b=7.435(6)Å c=21.367(16)Å
α=90° β=103.041(15)° γ=90°
4-Allyl-6-bromo-2-(4-chlorophenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C15H11BrClN3
Acta Crystallographica Section E (2019) 75, 1 43-48
a=7.6218(5)Å b=8.5238(5)Å c=11.1093(7)Å
α=95.739(3)° β=98.880(3)° γ=94.979(3)°
1-[(1-Butyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3-methylquinoxalin-2(1<i>H</i>)-one
C16H19N5O
Acta Crystallographica Section E (2018) 74, 12 1815-1820
a=5.3265(2)Å b=9.9946(4)Å c=14.5414(5)Å
α=103.054(2)° β=100.039(2)° γ=93.108(2)°
5-Methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine
C6H6N4
Acta Crystallographica Section E (2018) 74, 12 1833-1837
a=3.7910(2)Å b=18.0092(10)Å c=9.0069(5)Å
α=90° β=101.704(2)° γ=90°
1-Benzyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C17H14N2O
Acta Crystallographica Section E (2018) 74, 12 1842-1846
a=8.3567(2)Å b=9.2040(2)Å c=17.7868(4)Å
α=90° β=94.5590(10)° γ=90°
1-{[2-Oxo-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-1-yl)methyl}-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C21H20N4O2
Acta Crystallographica Section E (2018) 74, 12 1746-1750
a=11.5244(5)Å b=8.6312(4)Å c=17.9845(8)Å
α=90° β=94.1340(10)° γ=90°
<i>catena</i>-Poly[[diaquabis(4-formylbenzoato-κ<i>O</i>^1^)cobalt(II)]-μ-pyrazine-κ^2^<i>N</i>:<i>N</i>]
C20H18CoN2O8
Acta Crystallographica Section E (2015) 71, 4 339-341
a=22.1623(6)Å b=7.1193(2)Å c=12.2911(3)Å
α=90.00° β=94.4320(10)° γ=90.00°
<i>catena</i>-Poly[[aquabis(4-formylbenzoato)-κ^2^<i>O</i>^1^,<i>O</i>^1^;κ<i>O</i>^1^-zinc]-μ-pyrazine-κ^2^<i>N</i>:<i>N</i>']
C20H16N2O7Zn
Acta Crystallographica Section E (2015) 71, 4 402-405
a=22.4721(7)Å b=7.1729(2)Å c=23.6377(8)Å
α=90.00° β=91.764(2)° γ=90.00°
<i>trans</i>-Diaquabis(4-cyanobenzoato-κ<i>O</i>)bis(nicotinamide-κ<i>N</i>^1^)cobalt(II)
C28H24CoN6O8
Acta Crystallographica Section E (2015) 71, 5 561-563
a=7.6474(3)Å b=9.9266(4)Å c=10.2782(4)Å
α=78.680(2)° β=84.200(3)° γ=71.556(2)°
Poly[bis(μ-nicotinamide-κ^2^<i>N</i>^1^:<i>O</i>)bis(μ-4-nitrobenzoato-κ^2^<i>O</i>^1^:<i>O</i>^1^)zinc]
C26H20N6O10Zn
Acta Crystallographica Section E (2015) 71, 5 479-482
a=9.5118(3)Å b=10.5591(3)Å c=14.5326(5)Å
α=109.846(4)° β=93.618(3)° γ=104.815(4)°
2-[2-(2,5-Dichlorobenzyloxy)-2-(furan-2-yl)ethyl]-2<i>H</i>-indazole
C20H16Cl2N2O2
Acta Crystallographica Section E (2016) 72, 10 1377-1379
a=7.7318(3)Å b=9.6675(4)Å c=12.8299(5)Å
α=76.511(4)° β=76.157(4)° γ=73.928(3)°
<i>trans</i>-Diaquabis(4-cyanobenzoato-κ<i>O</i>)bis(<i>N</i>,<i>N</i>-diethylnicotinamide-κ<i>N</i>)zinc(II)
C36H40N6O8Zn
Acta Crystallographica Section E (2016) 72, 10 1374-1376
a=7.4916(3)Å b=8.5915(3)Å c=15.0343(6)Å
α=86.363(3)° β=75.894(2)° γ=74.390(2)°
<i>trans</i>-Diaquabis(4-cyanobenzoato-κ<i>O</i>)bis(<i>N</i>,<i>N</i>-diethylnicotinamide-κ<i>N</i>)cadmium
C36H40CdN6O8
Acta Crystallographica Section E (2016) 72, 12 1827-1829
a=7.5125(2)Å b=8.6671(3)Å c=15.3079(5)Å
α=86.198(3)° β=76.249(4)° γ=74.730(3)°
Bis(μ-3-nitrobenzoato)-κ^3^<i>O</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>O</i>,<i>O</i>'-bis[bis(3-cyanopyridine-κ<i>N</i>^1^)(3-nitrobenzoato-κ^2^<i>O</i>,<i>O</i>')cadmium]
C52H32Cd2N12O16
Acta Crystallographica Section E (2017) 73, 3 413-416
a=8.5237(3)Å b=12.7145(4)Å c=13.0583(5)Å
α=105.022(3)° β=97.347(3)° γ=104.866(2)°
(4<i>Z</i>)-1-Butyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C16H20N2O2
Acta Crystallographica Section E (2018) 74, 11 1669-1673
a=9.1132(6)Å b=12.6676(9)Å c=12.8164(9)Å
α=91.3440(10)° β=99.5370(10)° γ=96.3400(10)°
Ethyl 2-{4-[(3-methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C16H17N5O3
Acta Crystallographica Section E (2018) 74, 11 1648-1652
a=7.2061(15)Å b=10.237(2)Å c=10.694(2)Å
α=95.356(3)° β=92.867(3)° γ=100.291(3)°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C20H16Cl2N2O3S
Acta Crystallographica Section E (2019) 75, 5 593-599
a=18.4615(8)Å b=12.8567(5)Å c=7.9251(4)Å
α=90° β=96.926(2)° γ=90°
(2<i>Z</i>)-2-(4-Fluorobenzylidene)-4-(prop-2-yn-1-yl)-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C18H12FNOS
Acta Crystallographica Section E (2019) 75, 3 372-377
a=4.0602(2)Å b=13.8983(5)Å c=14.2620(5)Å
α=117.809(2)° β=93.155(2)° γ=94.416(2)°
3-(4,4-Dimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-ylidene)-6-methyl-3,4-dihydro-2<i>H</i>-pyran-2,4-dione
C17H18N2O3
Acta Crystallographica Section E (2019) 75, 2 228-232
a=5.53730(10)Å b=24.0197(4)Å c=11.7815(3)Å
α=90° β=103.488(2)° γ=90°
5,5-Diphenyl-1,3-bis(prop-2-yn-1-yl)imidazolidine-2,4-dione
C21H16N2O2
Acta Crystallographica Section E (2019) 75, 7 951-956
a=10.144(3)Å b=7.952(2)Å c=10.928(3)Å
α=90° β=97.104(12)° γ=90°
3-{(2<i>Z</i>)-2-[(2,4-Dichlorophenyl)methylidene]-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl}propanenitrile
C18H12Cl2N2OS
Acta Crystallographica Section E (2019) 75, 6 721-727
a=6.5687(6)Å b=7.9971(7)Å c=15.4939(13)Å
α=98.105(4)° β=94.316(4)° γ=95.002(4)°
2-Chloroethyl 2-oxo-1-(prop-2-yn-1-yl)-1,2-dihydroquinoline-4-carboxylate
C15H12ClNO3
Acta Crystallographica Section E (2019) 75, 10 1411-1417
a=7.1809(2)Å b=21.4466(5)Å c=8.9173(2)Å
α=90° β=92.784(2)° γ=90°
5-Bromo-1-{2-[2-(2-chloroethoxy)ethoxy]ethyl}indoline-2,3-dione
C14H15BrClNO4
Acta Crystallographica Section E (2019) 75, 9 1372-1378
a=12.4682(4)Å b=14.6397(5)Å c=8.3524(3)Å
α=90° β=91.392(2)° γ=90°
4-[(Prop-2-en-1-yloxy)methyl]-3,6-bis(pyridin-2-yl)pyridazine
C18H16N4O
Acta Crystallographica Section E (2019) 75, 9 1321-1326
a=8.9420(2)Å b=15.1130(3)Å c=11.5829(3)Å
α=90° β=100.1320(10)° γ=90°
3,6-Bis(pyridin-2-yl)-4-{[(3a<i>S</i>,5<i>S</i>,5a<i>R</i>,8a<i>R</i>,8b<i>S</i>)-2,2,7,7-tetramethyltetrahydro-5<i>H</i>-bis[1,3]dioxolo[4,5-<i>b</i>:4',5'-<i>d</i>]pyran-5-yl)methoxy]methyl}pyridazine monohydrate
C27H30N4O6,H2O
Acta Crystallographica Section E (2019) 75, 8 1169-1174
a=8.8417(3)Å b=11.3252(3)Å c=25.7003(8)Å
α=90° β=90° γ=90°
<i>trans</i>-Diaquabis(nicotinamide-κ<i>N</i>^1^)bis(4-nitrobenzoato-κ<i>O</i>)manganese(II)
C26H24MnN6O12
Acta Crystallographica Section E (2016) 72, 5 656-658
a=7.6051(3)Å b=10.0027(4)Å c=10.2152(4)Å
α=78.067(3)° β=88.430(4)° γ=71.746(3)°
Diaquabis(<i>N</i>,<i>N</i>-diethylnicotinamide-κ<i>N</i>^1^)bis(2,4,6-trimethylbenzoato-κ<i>O</i>^1^)cobalt(II)
C40H54CoN4O8
Acta Crystallographica Section E (2016) 72, 4 498-501
a=12.9646(4)Å b=10.8636(3)Å c=15.6297(5)Å
α=90.00° β=111.596(3)° γ=90.00°
<i>catena</i>-Poly[[aquabis(4-cyanobenzoato-κ<i>O</i>)copper(II)]-μ-<i>N</i>,<i>N</i>-diethylnicotinamide-κ^2^<i>N</i>^1^:<i>O</i>]
C26H24CuN4O6
Acta Crystallographica Section E (2016) 72, 8 1183-1186
a=14.6207(4)Å b=8.0160(3)Å c=22.2892(5)Å
α=90.00° β=101.725(3)° γ=90.00°
Diaquabis(4-<i>tert</i>-butylbenzoato-κ<i>O</i>)bis(nicotinamide-κ<i>N</i>^1^)cobalt(II) dihydrate
C34H42CoN4O8,2(H2O)
Acta Crystallographica Section E (2016) 72, 7 888-891
a=7.9608(5)Å b=10.0679(6)Å c=12.3007(7)Å
α=72.087(2)° β=74.841(3)° γ=78.660(3)°
(<i>E</i>)-4-{[2-(4-Hydroxybenzoyl)hydrazin-1-ylidene]methyl}pyridin-1-ium nitrate
C13H12N3O2,NO3
Acta Crystallographica Section E (2018) 74, 3 323-327
a=8.335(3)Å b=13.929(5)Å c=12.184(4)Å
α=90.00° β=95.902(10)° γ=90.00°
Tetrakis(μ-2,4,6-trimethylbenzoato-κ^2^<i>O</i>:<i>O</i>)bis[(nicotinamide-κ<i>N</i>^1^)copper(II)]
C52H56Cu2N4O10
Acta Crystallographica Section E (2015) 71, 8 989-992
a=27.9186(7)Å b=17.2843(5)Å c=10.7570(3)Å
α=90.00° β=98.204(2)° γ=90.00°
Triaqua(4-cyanobenzoato-κ^2^<i>O</i>,<i>O</i>)(nicotinamide-κ<i>N</i>^1^)zinc 4-cyanobenzoate
C14H16N3O6Zn,C8H4NO2
Acta Crystallographica Section E (2015) 71, 6 684-686
a=6.0858(2)Å b=8.7031(3)Å c=22.2357(6)Å
α=81.882(2)° β=87.806(3)° γ=88.007(3)°
4-({5-[(<i>E</i>)-(3,5-Difluorophenyl)diazenyl]-2-hydroxybenzylidene}amino)-2,2,6,6-tetramethylpiperidin-1-oxyl
C22H25F2N4O2
Acta Crystallographica Section E (2015) 71, 7 864-866
a=13.5115(3)Å b=23.1062(5)Å c=13.8677(3)Å
α=90.00° β=100.639(3)° γ=90.00°
4-(3,4-Dicyanophenoxy)-<i>N</i>-[3-(dimethylamino)propyl]benzamide monohydrate
C20H20N4O2,H2O
Acta Crystallographica Section E (2015) 71, 9 1042-1044
a=12.9004(4)Å b=10.5012(3)Å c=14.1343(4)Å
α=90.00° β=99.819(5)° γ=90.00°
Diaquabis(<i>N</i>,<i>N</i>-diethylnicotinamide-κ<i>N</i>^1^)bis(2,4,6-trimethylbenzoato-κ<i>O</i>)manganese(II)
C40H54MnN4O8
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 4 422-427
a=13.1040(4)Å b=10.8828(3)Å c=15.7167(4)Å
α=90.00° β=111.570(2)° γ=90.00°
Aquabis(nicotinamide-κ<i>N</i>)bis(4-sulfamoylbenzoato-κ<i>O</i>^1^)copper(II)
C26H26CuN6O11S2
Acta crystallographica. Section E, Crystallographic communications (2018) 74, Pt 1 45-50
a=24.2353(4)Å b=5.6080(2)Å c=24.9702(4)Å
α=90.00° β=118.027(11)° γ=90.00°
Hexakis(μ-benzoato-κ^2^<i>O</i>:<i>O</i>)bis(pyridine-3-carbonitrile-κ<i>N</i>^1^)trizinc(II)
C54H38N4O12Zn3
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1966-1970
a=21.7698(4)Å b=10.7768(2)Å c=22.2272(4)Å
α=90.00° β=90.00° γ=90.00°
Aquabis(nicotinamide-κ<i>N</i>^1^)bis(2,4,6-trimethylbenzoato-κ<i>O</i>)zinc
C32H36N4O7Zn
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 9 1348-1352
a=23.4004(5)Å b=15.1685(4)Å c=9.2353(3)Å
α=90.00° β=90.00° γ=90.00°
<i>catena</i>-Poly[[[diaquabis(2,4,6-trimethylbenzoato-κ<i>O</i>)cobalt(II)]-μ-aqua-κ^2^<i>O</i>:<i>O</i>] dihydrate]
C20H28CoO7,2(H2O)
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 5 708-712
a=29.5261(5)Å b=10.1413(2)Å c=8.0906(2)Å
α=90.00° β=91.894(4)° γ=90.00°
Dimethyl 3,6-dioxatetracyclo[6.1.0.0^2,4^.0^5,7^]nonane-2,9-dicarboxylate
C11H12O6
Acta Crystallographica Section E (2006) 62, 5 o1991-o1993
a=12.3492(9)Å b=9.0553(14)Å c=19.813(2)Å
α=90.00° β=90.00° γ=90.00°
6,6'-dichloro-3,3''etheno-3,4,3'',4''-tetrahydro-2H-1,3-benzoxazine-2-spiro- 2'-(2λ^5^,4λ^5^,6λ^5^-cyclotriphosphazene)-4'-spiro-2''-2H-1,3-benzoxazine
C16H16Cl2N5O2P3
Acta Crystallographica Section E (2004) 60, 5 o795-o797
a=15.8433(12)Å b=6.6557(14)Å c=20.1339(10)Å
α=90.00° β=112.814(5)° γ=90.00°
7,11-[Butane-1,4-diyldioxydi-o-phenylenedimethylene]-6,6-dichloro- 4,4-bis(pyrrolidin-1-yl)-2λ^5^,4λ^5^,6λ^5^-triphosphaza-1,3,5,7,11- pentaazaspiro[5.5]undeca-1,3,5-triene
C29H42Cl2N7O2P3
Acta Crystallographica Section E (2005) 61, 7 o2145-o2147
a=9.2618(4)Å b=23.6323(8)Å c=15.1606(7)Å
α=90.00° β=103.023(4)° γ=90.00°
C15H17N1O2
C15H17N1O2
Acta Crystallographica Section E (2002) 58, 11 o1255-o1257
a=10.2221(10)Å b=7.5133(10)Å c=17.539(2)Å
α=90.00° β=101.603(9)° γ=90.00°
N-(2-Benzyloxyethyl)-4,7-dimethyl-6-(1,3-dithiolan-2-yl)-1,2,3,4,5,6- hexahydro-1,5-methano-2-azocino[4,3-b]indol-2-one
C27H30N2O2S2
Acta Crystallographica Section E (2004) 60, 1 o25-o27
a=7.8787(10)Å b=12.446(2)Å c=24.501(3)Å
α=90.00° β=90.00° γ=90.00°
4,4',6',6'-Tetrachloro-3-(4,6-dimethylpyridin-2-yl)-3,4-dihydrospiro[1,3,2- benzoxazaphosphinine-2,2'-(2λ^5^,4λ^5^,6λ^5^-cyclotriphosphazene)]
C14H14Cl4N5OP3
Acta Crystallographica Section E (2005) 61, 6 o1557-o1560
a=7.9310(5)Å b=11.9091(10)Å c=21.3948(15)Å
α=90.00° β=90.00° γ=90.00°
3-(4-Chlorophenyldiazenyl)-1-methyl-2-phenyl-1H-indole
C21H16ClN3
Acta Crystallographica Section E (2006) 62, 6 o2108-o2110
a=8.0836(10)Å b=27.952(4)Å c=30.483(3)Å
α=90.00° β=90.00° γ=90.00°
(1R,3S,4S,6R)-1,2,3,4,5,6-hexabromo-1,2,3,4,5,6-hexahydropentalene-- (1R,2R,4S,5S)-1,2,3,4,5,6-hexabromo-1,2,4,5-tetrahydropentalene (1/1)
C8H6Br6,C8H4Br6
Acta Crystallographica Section E (2006) 62, 6 o2466-o2468
a=8.258(2)Å b=8.483(2)Å c=10.850(5)Å
α=72.274(3)° β=71.128(3)° γ=69.733(2)°
C19H14O6
C19H14O6
Acta Crystallographica Section E (2002) 58, 1 o30-o32
a=8.3574(10)Å b=9.5422(10)Å c=19.775(2)Å
α=90° β=96.197(8)° γ=90°
C16H15N1O2
C16H15N1O2
Acta Crystallographica Section E (2002) 58, 2 o206-o208
a=7.2919(10)Å b=9.0198(10)Å c=19.583(2)Å
α=90.00° β=92.798(9)° γ=90.00°
C14H8Br6
C14H8Br6
Acta Crystallographica Section E (2002) 58, 1 o10-o12
a=7.9289(10)Å b=8.4017(10)Å c=13.2850(10)Å
α=79.759(5)° β=82.136(6)° γ=72.503(5)°
C26H16Cl2N7O12P3,C2H3N
C26H16Cl2N7O12P3,C2H3N
Acta Crystallographica Section E (2002) 58, 1 o20-o23
a=11.5487(10)Å b=11.8570(10)Å c=15.0238(10)Å
α=97.493(10)° β=109.989(10)° γ=109.776(10)°
C22H26N2O2S2
C22H26N2O2S2
Acta Crystallographica Section E (2002) 58, 4 o374-o376
a=8.6833(10)Å b=22.975(2)Å c=9.9726(10)Å
α=90.00° β=94.675(10)° γ=90.00°
C26H22N4O8Zn
C26H22N4O8Zn
Acta Crystallographica Section E (2002) 58, 12 m758-m761
a=10.3159(10)Å b=22.606(3)Å c=10.8926(10)Å
α=90.00° β=95.375(6)° γ=90.00°
2-Methoxymethyl-1,3-dithiolane 1,1,3,3-tetraoxide
C5H10O5S2
Acta Crystallographica Section E (2003) 59, 6 o747-o749
a=6.7699(10)Å b=9.1736(13)Å c=14.5311(19)Å
α=77.910(11)° β=85.013(11)° γ=86.886(12)°
N-Hydroxy-2-oxo-2,N'-diphenylacetamidine
C14H12N2O2
Acta Crystallographica Section E (2003) 59, 6 o883-o885
a=10.0106(9)Å b=10.2280(6)Å c=12.1627(7)Å
α=90.00° β=95.763(6)° γ=90.00°
C20H26N2O3,0.5H2O
C20H26N2O3,0.5H2O
Acta Crystallographica Section E (2003) 59, 11 o1607-o1609
a=24.457(2)Å b=7.5165(12)Å c=23.865(2)Å
α=90.00° β=116.768(9)° γ=90.00°
C5H10O3S2
C5H10O3S2
Acta Crystallographica Section E (2003) 59, 10 o1541-o1543
a=14.4429(19)Å b=6.3787(8)Å c=8.8867(10)Å
α=90.00° β=99.260(14)° γ=90.00°
C11H16OS2
C11H16OS2
Acta Crystallographica Section E (2003) 59, 7 o926-o928
a=6.748(4)Å b=7.870(4)Å c=11.474(7)Å
α=99.23(4)° β=103.00(5)° γ=102.69(3)°
C16H21NO5
C16H21NO5
Acta Crystallographica Section E (2003) 59, 8 o1220-o1222
a=9.3947(18)Å b=14.195(3)Å c=11.7723(11)Å
α=90.00° β=99.213(12)° γ=90.00°
C7H14O5S2
C7H14O5S2
Acta Crystallographica Section E (2003) 59, 9 o1251-o1253
a=7.8972(9)Å b=14.627(2)Å c=9.5192(10)Å
α=90.00° β=108.739(8)° γ=90.00°
N-(3-chloro-4-methylphenyl)-N'-hydroxy-2-oxo-2-phenylacetamidine
C15H13ClN2O2
Acta Crystallographica Section E (2004) 60, 3 o406-o408
a=25.6412(14)Å b=4.9773(3)Å c=22.3894(16)Å
α=90.00° β=90.00° γ=90.00°
C14H28O2S4
C14H28O2S4
Acta Crystallographica Section E (2004) 60, 2 o157-o159
a=10.5512(10)Å b=10.4538(12)Å c=8.2152(10)Å
α=90.00° β=91.061(10)° γ=90.00°
Cis-(1RS,3RS)-2-Methoxymethyl-1,3-dithiane 1,3-dioxide
C6H12O3S2
Acta Crystallographica Section E (2004) 60, 9 o1624-o1626
a=7.8086(12)Å b=10.3018(18)Å c=10.8659(12)Å
α=90.00° β=92.528(10)° γ=90.00°
4,4,6,6-Tetrachloro-1,3'-[2,2'-(3-oxapentane-1,5-dioxy)dibenzyl]- 2λ^5^,4λ^5^,6λ^5^-cyclotriphosphazene-2-spiro-2'-1,3,2-diazaphospholane benzene hemisolvate
C20H24Cl4N5O3P3,0.5C6H6
Acta Crystallographica, Section E (2004) 60, 8 o1369-o1372
a=18.531(5)Å b=13.431(3)Å c=24.043(4)Å
α=90.00° β=95.23(2)° γ=90.00°